Anatomical Therapeutic Chemical • L02BX04 • relugolix

L Antineoplastic and immunomodulating agents

L01 Antineoplastic agents

L02 Endocrine therapy

L02A Hormones and related agents

L02B Hormone antagonists and related agents

L02BA Anti-estrogens

L02BB Anti-androgens

L02BG Aromatase inhibitors

L02BX Other hormone antagonists and related agents

L02BX02 degarelix Indicated for: prostate cancer

L02BX03 abiraterone Indicated for: prostate cancer

L02BX04 relugolix Indicated for: prostate cancer

L03 Immunostimulants

L04 Immunosuppressants